Key financial ranges
Market cap · USD equivalent−∞—+∞
P/E ratio−∞—+∞
Annual revenue · USD equivalent−∞—+∞
Revenue growth−∞—+∞
5,361–5,380 of 6,553
CompanyMarket capP/ERevenueRev. growthNet incomeCashDebtAI value
CNSPCNS Pharmaceuticals, Inc.$8.62M————$19.99M$482.38KAI pending
OSRHOSR Health, Inc.$8.6M—$2.91M-17.7%-$27.06M$1.5M$2.68MAI pending
ELOGEastern International Ltd.$8.6M—$45.63M+14.0%-$1.15M$3.29M$6.89MAI pending
IMRNImmuron Ltd$8.6M—A$7.29M+48.6%-A$5.22MA$2.83MA$173.5KAI pending
GELSGelteq Ltd$8.59M—A$165.65K+107.5%-A$6.65MA$344.65KA$4.99MAI pending
PCMCPublic Co Management Corp$8.57M————$6.69K$450KAI pending
ENSCEnsysce Biosciences, Inc.$8.55M—$5.07M-2.8%-$10.18M$676.7K$2.73KAI pending
GAUZGauzy Ltd.$8.51M—$103.53M+32.8%-$53.18M$1.24M$54.22MAI pending
MBAICheck-Cap Ltd$8.49M1.2×———$2K$16KAI pending
TRAWTraws Pharma, Inc.$8.45M—$2.79M+1,134.5%$9.17M$5.02M$0AI pending
EVTKEventiko Inc.$8.39M—$0—-$23.87K$0—AI pending
EVGNEvogene Ltd.$8.38M—$3.85M-30.9%-$7.83M$12.96M$2.2MAI pending
XWELXWELL, Inc.$8.36M—$29.21M-13.8%-$16.99M$11.78M$7.29MAI pending
CODXCo-Diagnostics, Inc.$8.36M—$622.49K-84.1%-$46.9M$3.65M$1.8MAI pending
SSMSono Group N.V.$8.35M————$166K$5.68MAI pending
SNGXSoligenix, Inc.$8.33M—$119.37K-85.8%-$8.27M$9.81M$302.59KAI pending
ALZNAlzamend Neuro, Inc.$8.3M————$710.69K—AI pending
SKYESkye Bioscience, Inc.$8.28M————$8.07M$35.7KAI pending
PDCPerpetuals.com Ltd$8.27M—$3.09M+171.2%-$1.8M$731.82K$363.45KAI pending
VPRBVPR Brands, LP.$8.24M8.2×$3.62M-36.3%-$1.2M$2.14M$41.91KAI pending